Welcome to AnavexTM Life Sciences Corp.
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.
Anavex corporate presentation at 18th Annual BIO CEO & Investor Conference on February 9, 2016
Anavex rings the Nasdaq Stock Market Closing Bell on Oct. 30, 2015
Reverse stock split associated with uplisting to Nasdaq Capital Market.